PMC:340383 / 19660-20172 JSONTXT 5 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function

Id Subject Object Predicate Lexical cue
T4823 0-8 NN denotes Antibody
T4824 9-19 NN denotes production
T4825 20-23 CC denotes and
T4826 24-31 NNP denotes Western
T4827 32-36 NN denotes blot
T4828 37-45 NNS denotes analyses
T4829 45-271 sentence denotes Peptides linked to KLH (keyhole limpet hemacyanin) from Acdp1 N- and C-terminals and the conserved domain (ACD) were used for generation of antibodies specifically for Acdp1 and all Acdp members as reported, respectively [5].
T4830 46-54 NNS denotes Peptides
T4832 55-61 VBN denotes linked
T4833 62-64 IN denotes to
T4834 65-68 NN denotes KLH
T4835 69-70 -LRB- denotes (
T4836 70-77 NN denotes keyhole
T4838 78-84 NN denotes limpet
T4837 85-95 NN denotes hemacyanin
T4839 95-96 -RRB- denotes )
T4840 97-101 IN denotes from
T4841 102-107 NN denotes Acdp1
T4843 108-109 NN denotes N
T4844 109-110 HYPH denotes -
T4845 111-114 CC denotes and
T4846 115-116 NN denotes C
T4847 116-117 HYPH denotes -
T4842 117-126 NNS denotes terminals
T4848 127-130 CC denotes and
T4849 131-134 DT denotes the
T4851 135-144 VBN denotes conserved
T4850 145-151 NN denotes domain
T4852 152-153 -LRB- denotes (
T4853 153-156 NN denotes ACD
T4854 156-157 -RRB- denotes )
T4855 158-162 VBD denotes were
T4831 163-167 VBN denotes used
T4856 168-171 IN denotes for
T4857 172-182 NN denotes generation
T4858 183-185 IN denotes of
T4859 186-196 NNS denotes antibodies
T4860 197-209 RB denotes specifically
T4861 210-213 IN denotes for
T4862 214-219 NN denotes Acdp1
T4863 220-223 CC denotes and
T4864 224-227 DT denotes all
T4866 228-232 NN denotes Acdp
T4865 233-240 NNS denotes members
T4867 241-243 IN denotes as
T4868 244-252 VBN denotes reported
T4869 252-254 , denotes ,
T4870 254-266 RB denotes respectively
T4871 267-268 -LRB- denotes [
T4872 268-269 CD denotes 5
T4873 269-270 -RRB- denotes ]
T4874 270-271 . denotes .
T4875 271-350 sentence denotes Western blots were carried out Using ECL (PIERCE) as described previously [1].
T4876 272-279 NNP denotes Western
T4877 280-285 NNS denotes blots
T4879 286-290 VBD denotes were
T4878 291-298 VBN denotes carried
T4880 299-302 RP denotes out
T4881 303-308 VBG denotes Using
T4882 309-312 NN denotes ECL
T4883 313-314 -LRB- denotes (
T4884 314-320 NN denotes PIERCE
T4885 320-321 -RRB- denotes )
T4886 322-324 IN denotes as
T4887 325-334 VBN denotes described
T4888 335-345 RB denotes previously
T4889 346-347 -LRB- denotes [
T4890 347-348 CD denotes 1
T4891 348-349 -RRB- denotes ]
T4892 349-350 . denotes .
T4893 350-512 sentence denotes The membranes were washed extensively after incubation with primary and secondary antibodies and were then developed with X-ray films with optimal exposure time.
T4894 351-354 DT denotes The
T4895 355-364 NNS denotes membranes
T4897 365-369 VBD denotes were
T4896 370-376 VBN denotes washed
T4898 377-388 RB denotes extensively
T4899 389-394 IN denotes after
T4900 395-405 NN denotes incubation
T4901 406-410 IN denotes with
T4902 411-418 JJ denotes primary
T4904 419-422 CC denotes and
T4905 423-432 JJ denotes secondary
T4903 433-443 NNS denotes antibodies
T4906 444-447 CC denotes and
T4907 448-452 VBD denotes were
T4909 453-457 RB denotes then
T4908 458-467 VBN denotes developed
T4910 468-472 IN denotes with
T4911 473-478 NN denotes X-ray
T4912 479-484 NNS denotes films
T4913 485-489 IN denotes with
T4914 490-497 JJ denotes optimal
T4916 498-506 NN denotes exposure
T4915 507-511 NN denotes time
T4917 511-512 . denotes .
R2904 T4823 T4824 compound Antibody,production
R2905 T4825 T4824 cc and,production
R2906 T4826 T4827 compound Western,blot
R2907 T4827 T4828 compound blot,analyses
R2908 T4828 T4824 conj analyses,production
R2909 T4830 T4831 nsubjpass Peptides,used
R2910 T4832 T4830 acl linked,Peptides
R2911 T4833 T4832 prep to,linked
R2912 T4834 T4833 pobj KLH,to
R2913 T4835 T4834 punct (,KLH
R2914 T4836 T4837 compound keyhole,hemacyanin
R2915 T4837 T4834 appos hemacyanin,KLH
R2916 T4838 T4837 compound limpet,hemacyanin
R2917 T4839 T4833 punct ),to
R2918 T4840 T4833 prep from,to
R2919 T4841 T4842 nmod Acdp1,terminals
R2920 T4842 T4840 pobj terminals,from
R2921 T4843 T4842 nmod N,terminals
R2922 T4844 T4843 punct -,N
R2923 T4845 T4843 cc and,N
R2924 T4846 T4843 conj C,N
R2925 T4847 T4842 punct -,terminals
R2926 T4848 T4842 cc and,terminals
R2927 T4849 T4850 det the,domain
R2928 T4850 T4842 conj domain,terminals
R2929 T4851 T4850 amod conserved,domain
R2930 T4852 T4850 punct (,domain
R2931 T4853 T4850 appos ACD,domain
R2932 T4854 T4831 punct ),used
R2933 T4855 T4831 auxpass were,used
R2934 T4856 T4831 prep for,used
R2935 T4857 T4856 pobj generation,for
R2936 T4858 T4857 prep of,generation
R2937 T4859 T4858 pobj antibodies,of
R2938 T4860 T4861 advmod specifically,for
R2939 T4861 T4856 prep for,for
R2940 T4862 T4861 pobj Acdp1,for
R2941 T4863 T4862 cc and,Acdp1
R2942 T4864 T4865 det all,members
R2943 T4865 T4862 conj members,Acdp1
R2944 T4866 T4865 compound Acdp,members
R2945 T4867 T4868 mark as,reported
R2946 T4868 T4831 advcl reported,used
R2947 T4869 T4831 punct ", ",used
R2948 T4870 T4831 advmod respectively,used
R2949 T4871 T4872 punct [,5
R2950 T4872 T4831 parataxis 5,used
R2951 T4873 T4872 punct ],5
R2952 T4874 T4831 punct .,used
R2953 T4876 T4877 compound Western,blots
R2954 T4877 T4878 nsubjpass blots,carried
R2955 T4879 T4878 auxpass were,carried
R2956 T4880 T4878 prt out,carried
R2957 T4881 T4878 advcl Using,carried
R2958 T4882 T4881 dobj ECL,Using
R2959 T4883 T4884 punct (,PIERCE
R2960 T4884 T4882 parataxis PIERCE,ECL
R2961 T4885 T4884 punct ),PIERCE
R2962 T4886 T4887 mark as,described
R2963 T4887 T4878 advcl described,carried
R2964 T4888 T4887 advmod previously,described
R2965 T4889 T4890 punct [,1
R2966 T4890 T4878 parataxis 1,carried
R2967 T4891 T4890 punct ],1
R2968 T4892 T4878 punct .,carried
R2969 T4894 T4895 det The,membranes
R2970 T4895 T4896 nsubjpass membranes,washed
R2971 T4897 T4896 auxpass were,washed
R2972 T4898 T4896 advmod extensively,washed
R2973 T4899 T4896 prep after,washed
R2974 T4900 T4899 pobj incubation,after
R2975 T4901 T4900 prep with,incubation
R2976 T4902 T4903 amod primary,antibodies
R2977 T4903 T4901 pobj antibodies,with
R2978 T4904 T4902 cc and,primary
R2979 T4905 T4902 conj secondary,primary
R2980 T4906 T4896 cc and,washed
R2981 T4907 T4908 auxpass were,developed
R2982 T4908 T4896 conj developed,washed
R2983 T4909 T4908 advmod then,developed
R2984 T4910 T4908 prep with,developed
R2985 T4911 T4912 compound X-ray,films
R2986 T4912 T4910 pobj films,with
R2987 T4913 T4912 prep with,films
R2988 T4914 T4915 amod optimal,time
R2989 T4915 T4913 pobj time,with
R2990 T4916 T4915 compound exposure,time
R2991 T4917 T4896 punct .,washed